세계의 단백질 검출 및 정량화 시장 : 제품, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Protein Detection & Quantification Market was valued at USD 2.56 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 8.98%, to USD 4.69 billion by 2030.

Protein detection and quantification refers to the technical processes used to identify and measure protein concentrations within a sample, which are crucial for understanding biological processes and disease mechanisms. This market's necessity stems from its critical role in advancing biomedical research, drug discovery, and clinical diagnostics, making it vital in fields like oncology, neurology, and infectious diseases. Applications span from academic research institutions to biotechnology companies, pharmaceutical manufacturers, and healthcare providers. The end-use scope also includes environmental monitoring and food safety testing, highlighting the technology's versatility. Market growth is predominantly driven by increasing research activities in proteomics, technological advancements such as the development of more sensitive and precise assays, and rising demand for personalized medicine. Emerging opportunities exist in expanding applications through digital technologies, AI integration for data analysis, and the development of innovative detection platforms like biosensors. However, challenges include high costs associated with advanced protein quantification platforms, complex data interpretation, and stringent regulatory requirements which can hinder fast adoption, especially in emerging markets. There is also a significant competitive landscape with numerous companies offering similar products, making differentiation essential. To capitalize on growth, businesses should focus on innovations like multiplex assays, which allow simultaneous detection of multiple proteins, thus offering comprehensive proteome analysis. Exploring partnerships with tech firms for AI and machine learning integration can also enhance data accuracy and efficiency. Additionally, focusing on cost-effective solutions to cater to budget-sensitive markets can expand reach. Market dynamics suggest a growing acknowledgment of the importance of proteins in disease understanding, but overcoming cost and complexity barriers will be critical for sustaining momentum. Opportunities for innovation and research lie in minimizing assay times, improving specificity and sensitivity, and broadening the application spectrum to less traditional sectors.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Detection & Quantification Market

The Protein Detection & Quantification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for protein quantification in clinical diagnostic testing and drug dosing
  • Higher adoption of infrared spectroscopy and immunoassay techniques
  • Growth in adoption of biomarkers and biologicals
• Market Restraints
  • Limited utilization and regulatory framework of these diagnostic tests and assays
• Market Opportunities
  • Rising advancements and development to shape the counters of global protein detection and quantification
  • Rising government funding in the proteomics and genomics to encourage personalized medicines
• Market Challenges
  • High cost of assays and technologies

Porter's Five Forces: A Strategic Tool for Navigating the Protein Detection & Quantification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Detection & Quantification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Detection & Quantification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Detection & Quantification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Detection & Quantification Market

A detailed market share analysis in the Protein Detection & Quantification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Detection & Quantification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Detection & Quantification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Detection & Quantification Market

A strategic analysis of the Protein Detection & Quantification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Aragen Life Sciences, Bio-Rad Laboratories, Bio-Techne, Biognosys Inc, Caltag Medsystems Limited, Charles River Laboratories, Cipla Ltd., Danaher Corporation, Elabscience Biotechnology Inc., GE Healthcare, Kaneka Eurogentec S.A., Megazyme Ltd., Merck KGaA, PerkinElmer, Inc, Promega Corporation, Sepmag Systems, SL, Shimadzu Scientific Instruments, Taisho Pharmaceutical, Takara Bio Inc., Thermo Fisher Scientific Inc, Unilever, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Protein Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Kits & Reagents/Consumables, and Services.
• Based on Technology, market is studied across Chromatography, Colorimetric Assays, Immunological methods, Mass Spectrometry, and Spectroscopy Instruments.
• Based on Application, market is studied across Clinical Diagnosis and Drug Discovery & Development.
• Based on End-User, market is studied across Academic Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for protein quantification in clinical diagnostic testing and drug dosing
    • 5.1.1.2. Higher adoption of infrared spectroscopy and immunoassay techniques
    • 5.1.1.3. Growth in adoption of biomarkers and biologicals
  • 5.1.2. Restraints
    • 5.1.2.1. Limited utilization and regulatory framework of these diagnostic tests and assays
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising advancements and development to shape the counters of global protein detection and quantification
    • 5.1.3.2. Rising government funding in the proteomics and genomics to encourage personalized medicines
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of assays and technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Detection & Quantification Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits & Reagents/Consumables
• 6.4. Services

7. Protein Detection & Quantification Market, by Technology

• 7.1. Introduction
• 7.2. Chromatography
• 7.3. Colorimetric Assays
• 7.4. Immunological methods
• 7.5. Mass Spectrometry
• 7.6. Spectroscopy Instruments

8. Protein Detection & Quantification Market, by Application

• 8.1. Introduction
• 8.2. Clinical Diagnosis
• 8.3. Drug Discovery & Development

9. Protein Detection & Quantification Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutes
• 9.3. Biotechnology & Pharmaceutical Companies
• 9.4. Contract Research Organization

10. Americas Protein Detection & Quantification Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Protein Detection & Quantification Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Protein Detection & Quantification Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies
• 2. Aragen Life Sciences
• 3. Bio-Rad Laboratories
• 4. Bio-Techne
• 5. Biognosys Inc
• 6. Caltag Medsystems Limited
• 7. Charles River Laboratories
• 8. Cipla Ltd.
• 9. Danaher Corporation
• 10. Elabscience Biotechnology Inc.
• 11. GE Healthcare
• 12. Kaneka Eurogentec S.A.
• 13. Megazyme Ltd.
• 14. Merck KGaA
• 15. PerkinElmer, Inc
• 16. Promega Corporation
• 17. Sepmag Systems, SL
• 18. Shimadzu Scientific Instruments
• 19. Taisho Pharmaceutical
• 20. Takara Bio Inc.
• 21. Thermo Fisher Scientific Inc
• 22. Unilever
• 23. Waters Corporation